NYSE$MMM
3M · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
3M delivered strong operational execution, restructuring actions, and proactive spending discipline, progressing with the Health Care spin-off and addressing legal matters.
3M reported Q3 2023 results, highlighting strong operational execution, restructuring actions, and proactive spending discipline. The company is progressing with the Health Care spin-off, expected to be completed in the first half of 2024, and addressing legal matters with the Combat Arms settlement and preliminary court approval for the PFAS Public Water Systems agreement.
- GAAP loss per share of $3.74 and operating margin of minus 31.9% include the previously announced settlement for Combat Arms, resulting in a pre-tax charge of $4.2 billion, negatively impacting EPS by $5.80.
- Adjusted EPS of $2.68 includes pre-tax restructuring related charges of $68 million, or negative $0.10 per share; restructuring program on track including forecasted full-year 2023 pre-tax restructuring charges and associated benefits.
- Adjusted EPS up 3 percent year-on-year.
- Adjusted operating income margin of 23.2% includes a 0.8 percentage point headwind from pre-tax restructuring related charges.
Headline financials
Revenue & EPS history
3M · Revenue · Quarterly
$8.31B
Revenue by segment
3M · $1.32B total across 1 segment · Q3 2023
- Consumer$1.32B-6.7%100.0%
Forward guidance
3M anticipates adjusted EPS to be in the range of $8.95 to $9.15 versus $8.60 to $9.10 prior. Adjusted operating cash flow is estimated in the range of $6.5 to $6.9 billion, contributing to 100 to 110 percent adjusted free cash flow conversion. Adjusted full-year total sales growth is forecasted to decline by approximately -5 percent versus a decline of -5 to -1 percent prior, reflecting a decline in adjusted organic sales of approximately -3 percent versus the lower end of -3 percent to flat prior.
Tailwinds
- Adjusted EPS2 to be in the range of $8.95 to $9.15 versus $8.60 to $9.10 prior.
- Adjusted operating cash flow2 is estimated in the range of $6.5 to $6.9 billion
- Adjusted free cash flow conversion2 of 100 to 110 percent
- Notification and registration process progressing on the Combat Arms Earplug agreement
- Received preliminary court approval for PFAS Public Water Systems agreement
Headwinds
- Adjusted full-year total sales growth2 is forecasted to decline by approximately -5 percent versus a decline of -5 to -1 percent prior
- Decline in adjusted organic sales2 of approximately -3 percent versus the lower end of -3 percent to flat prior.
- Impact of Combat Arms Earplug settlement
- Uncertainty in global economic conditions
- Risks related to PFAS-related products and chemistries
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
-0.0%
Avg return
Earnings day
-0.4%
Avg return
5 days after
-0.2%
Avg return
30 days after
48%
35 / 73 earnings
Positive
+21.1%
Q2 2024
Best reaction
-13.7%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.9% | -3.6% | -0.1% | |
| Q4 2025 | -7.0% | -3.1% | -1.6% | |
| Q3 2025 | +7.9% | +8.9% | +6.4% | |
| Q2 2025 | -2.2% | -3.7% | -1.5% | |
| Q1 2025 | +8.1% | +8.9% | +18.8% | |
| Q4 2024 | +5.7% | +6.0% | +5.7% | |
| Q3 2024 | -5.1% | -7.5% | -5.6% | |
| Q2 2024 | +21.1% | +23.4% | +26.3% | |
| Q1 2024 | +6.8% | +5.4% | +6.6% | |
| Q4 2023 | -13.7% | -11.1% | -14.6% | |
| Q3 2023 | +4.4% | +2.2% | +11.4% | |
| Q2 2023 | +8.0% | +7.3% | -5.5% | |
| Q1 2023 | -2.0% | +1.1% | -7.6% | |
| Q4 2022 | -7.9% | -4.6% | -10.6% | |
| Q3 2022 | +3.7% | +6.9% | +8.1% | |
| Q2 2022 | +3.5% | +6.8% | +6.4% | |
| Q1 2022 | -3.0% | -2.9% | -1.0% | |
| Q4 2021 | -2.0% | -2.6% | -11.8% | |
| Q3 2021 | -2.3% | -2.0% | -2.6% | |
| Q2 2021 | -1.7% | -1.8% | -3.1% | |
| Q1 2021 | -1.9% | -1.2% | +1.8% | |
| Q4 2020 | +9.5% | +3.1% | +4.9% | |
| Q3 2020 | -4.6% | -3.7% | +6.6% | |
| Q2 2020 | -4.3% | -7.8% | +0.5% | |
| Q1 2020 | +1.7% | -3.3% | +2.1% | |
| Q4 2019 | -7.8% | -9.7% | -14.5% | |
| Q3 2019 | -1.6% | +0.0% | -0.7% | |
| Q2 2019 | -3.0% | -1.0% | -13.1% | |
| Q1 2019 | -12.5% | -13.5% | -24.2% | |
| Q4 2018 | +3.1% | +3.1% | +7.3% | |
| Q3 2018 | -8.4% | -8.1% | -1.3% | |
| Q2 2018 | +2.8% | +4.3% | +2.0% | |
| Q1 2018 | -7.9% | -9.2% | -7.6% | |
| Q4 2017 | +4.4% | +1.6% | -4.3% | |
| Q3 2017 | +7.3% | +6.0% | +4.5% | |
| Q2 2017 | -5.2% | -4.9% | -3.8% | |
| Q1 2017 | +0.4% | +0.8% | +2.7% | |
| Q4 2016 | -1.0% | -0.6% | +4.9% | |
| Q3 2016 | -2.8% | -3.2% | +0.6% | |
| Q2 2016 | -0.8% | -0.7% | -0.0% | |
| Q1 2016 | -0.4% | — | — | |
| Q4 2015 | +5.8% | — | — | |
| Q3 2015 | +4.0% | — | — | |
| Q2 2015 | -3.9% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | -0.2% | — | — | |
| Q3 2014 | +6.9% | — | — | |
| Q2 2014 | +0.3% | — | — | |
| Q1 2014 | -1.0% | — | — | |
| Q4 2013 | -1.6% | — | — | |
| Q3 2013 | +1.0% | — | — | |
| Q2 2013 | +0.5% | — | — | |
| Q1 2013 | -3.8% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | -4.5% | — | — | |
| Q2 2012 | +3.3% | — | — | |
| Q1 2012 | +1.9% | — | — | |
| Q4 2011 | +0.6% | — | — | |
| Q3 2011 | +1.6% | — | — | |
| Q2 2011 | -4.0% | — | — | |
| Q1 2011 | +0.7% | — | — | |
| Q4 2010 | +0.8% | — | — | |
| Q3 2010 | -1.3% | — | — | |
| Q2 2010 | +0.6% | — | — | |
| Q1 2009 | -3.9% | — | — | |
| Q1 2010 | -0.5% | — | — | |
| Q4 2009 | +1.2% | — | — | |
| Q4 2007 | +1.2% | — | — | |
| Q3 2009 | -1.6% | — | — | |
| Q3 2008 | -1.6% | — | — | |
| Q4 2008 | +3.2% | — | — | |
| Q2 2009 | +3.2% | — | — | |
| Q2 2008 | +3.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro